Patents Assigned to Xiamen Vivohealths Technology Co., Ltd.
  • SUBSTITUTED IMIDAZOLE SALT COMPOUNDS, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION THEREOF AND APPLICATION THEREOF
    Publication number: 20230202986
    Abstract: Disclosed in the invention are a type of compounds having aldolase selective inhibitory activity, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for inhibiting triglyceride and cholesterol synthesis, for reducing fatty acid synthesis, for preventing and/or treating obesity and type II diabetes, for preventing and/or treating tumor, for preventing and/or treating Parkinson's disease, for preventing and/or treating Alzheimer's disease or for prolonging the lifespan of mammals:
    Type: Application
    Filed: January 17, 2023
    Publication date: June 29, 2023
    Applicant: Xiamen Vivohealths Technology Co., Ltd.
    Inventors: Xianming Deng, Shengcai Lin, Chensong Zhang
  • Substituted imidazole salt compounds, preparation method thereof, pharmaceutical composition thereof and application thereof
    Patent number: 11584722
    Abstract: Disclosed in the invention are a type of compounds having aldolase selective inhibitory activity, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for inhibiting triglyceride and cholesterol synthesis, for reducing fatty acid synthesis, for preventing and/or treating obesity and type II diabetes, for preventing and/or treating tumor, for preventing and/or treating Parkinson's disease, for preventing and/or treating Alzheimer's disease or for prolonging the lifespan of mammals:
    Type: Grant
    Filed: April 4, 2018
    Date of Patent: February 21, 2023
    Assignee: Xiamen Vivohealths Technology Co., Ltd.
    Inventors: Xianming Deng, Shengcai Lin, Chensong Zhang
  • SUBSTITUTED IMIDAZOLE SALT COMPOUNDS, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION THEREOF AND APPLICATION THEREOF
    Publication number: 20200109122
    Abstract: Disclosed in the invention are a type of compounds having aldolase selective inhibitory activity, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for inhibiting triglyceride and cholesterol synthesis, for reducing fatty acid synthesis, for preventing and/or treating obesity and type II diabetes, for preventing and/or treating tumor, for preventing and/or treating Parkinson's disease, for preventing and/or treating Alzheimer's disease or for prolonging the lifespan of mammals:
    Type: Application
    Filed: April 4, 2018
    Publication date: April 9, 2020
    Applicant: Xiamen Vivohealths Technology Co., Ltd.
    Inventors: Xianming Deng, Shengcai Lin, Chensong Zhang